<?xml version="1.0" encoding="UTF-8"?>
<p id="Par88">By now it has been widely publicized and generally accepted that COVID-19 patients are variably susceptible to “cytokine storm.” Bases for this variability are unknown. In asymptomatic individuals with COVID-19 there seems to be less active immune responses than in symptomatic individuals [
 <xref ref-type="bibr" rid="CR115">115</xref>]. It has been reported that within 19 days of symptom onset, all patients test positive for antiviral immunoglobulin-G (IgG) [
 <xref ref-type="bibr" rid="CR114">114</xref>]. These findings suggest that symptomatic patients have more active immune responses.
</p>
